Immunoprecise Free Cash Flow vs Earnings before Tax Analysis

Immunoprecise Antibodies financial indicator trend analysis is infinitely more than just investigating Immunoprecise Antibodies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunoprecise Antibodies is a good investment. Please check the relationship between Immunoprecise Antibodies Free Cash Flow and its Earnings before Tax accounts. Check out Risk vs Return Analysis.

Free Cash Flow vs Earnings before Tax

Free Cash Flow vs Earnings before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunoprecise Antibodies Free Cash Flow account and Earnings before Tax. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Immunoprecise Antibodies' Free Cash Flow and Earnings before Tax is 0.86. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Earnings before Tax in the same time period over historical financial statements of Immunoprecise Antibodies, assuming nothing else is changed. The correlation between historical values of Immunoprecise Antibodies' Free Cash Flow and Earnings before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Immunoprecise Antibodies are associated (or correlated) with its Earnings before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Earnings before Tax has no effect on the direction of Free Cash Flow i.e., Immunoprecise Antibodies' Free Cash Flow and Earnings before Tax go up and down completely randomly.

Correlation Coefficient

0.86
Relationship DirectionPositive 
Relationship StrengthStrong

Free Cash Flow

Free Cash Flow is a measure of financial performance calculated as Net Cash Flow from Operations minus Capital Expenditure.

Earnings before Tax

Earnings Before Tax is calculated by adding Income Tax Expense back to Net Income.
Most indicators from Immunoprecise Antibodies fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis.The current year Issuance Purchase of Equity Shares is expected to grow to about 54.8 M, whereas Selling General and Administrative Expense is forecasted to decline to about 8.7 M.
 2019 2020 2021 2022 (projected)
Interest Expense537 K517 K594.55 K596.14 K
Gross Profit8.03 M11.54 M13.27 M11.78 M

Immunoprecise Antibodies fundamental ratios Correlations

0.98-0.960.980.58-0.990.920.651.0-0.960.990.820.82-0.7-0.960.821.00.930.851.0-0.55
0.98-0.971.00.62-1.00.90.680.98-0.960.990.840.84-0.7-0.950.840.980.930.850.98-0.59
-0.96-0.97-0.97-0.70.96-0.91-0.73-0.950.97-0.99-0.9-0.90.680.92-0.89-0.98-0.94-0.89-0.960.68
0.981.0-0.970.6-1.00.890.650.98-0.950.990.820.82-0.72-0.960.820.980.920.840.98-0.56
0.580.62-0.70.6-0.60.840.990.55-0.780.640.940.940.04-0.380.940.660.830.920.6-1.0
-0.99-1.00.96-1.0-0.6-0.91-0.66-0.990.96-0.99-0.82-0.820.690.95-0.82-0.99-0.93-0.85-0.990.56
0.920.9-0.910.890.84-0.910.90.9-0.990.930.950.95-0.37-0.770.960.951.00.980.92-0.82
0.650.68-0.730.650.99-0.660.90.63-0.840.70.960.960.0-0.440.960.720.880.960.67-0.98
1.00.98-0.950.980.55-0.990.90.63-0.950.990.790.79-0.72-0.960.790.990.920.831.0-0.52
-0.96-0.960.97-0.95-0.780.96-0.99-0.84-0.95-0.97-0.94-0.940.520.86-0.94-0.98-0.99-0.96-0.970.76
0.990.99-0.990.990.64-0.990.930.70.99-0.970.860.86-0.69-0.950.861.00.950.870.99-0.61
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
-0.7-0.70.68-0.720.040.69-0.370.0-0.720.52-0.69-0.29-0.290.88-0.28-0.65-0.43-0.27-0.69-0.06
-0.96-0.950.92-0.96-0.380.95-0.77-0.44-0.960.86-0.95-0.66-0.660.88-0.66-0.93-0.8-0.68-0.950.35
0.820.84-0.890.820.94-0.820.960.960.79-0.940.861.01.0-0.28-0.660.870.960.990.83-0.93
1.00.98-0.980.980.66-0.990.950.720.99-0.981.00.870.87-0.65-0.930.870.960.891.0-0.63
0.930.93-0.940.920.83-0.931.00.880.92-0.990.950.960.96-0.43-0.80.960.960.980.94-0.81
0.850.85-0.890.840.92-0.850.980.960.83-0.960.870.990.99-0.27-0.680.990.890.980.86-0.9
1.00.98-0.960.980.6-0.990.920.671.0-0.970.990.820.82-0.69-0.950.831.00.940.86-0.57
-0.55-0.590.68-0.56-1.00.56-0.82-0.98-0.520.76-0.61-0.93-0.93-0.060.35-0.93-0.63-0.81-0.9-0.57
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Immunoprecise Antibodies Investors Sentiment

The influence of Immunoprecise Antibodies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunoprecise. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunoprecise Antibodies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunoprecise Antibodies' short interest history, or implied volatility extrapolated from Immunoprecise Antibodies options trading.

Current Sentiment - IPA

Immunoprecise Antibodies Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Immunoprecise Antibodies. What is your judgment towards investing in Immunoprecise Antibodies? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Tools for Immunoprecise Stock

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go